EuRSV / EuBiologics - LARVOL DELTA

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years (clinicaltrials.gov) - P1 | N=100 | Active, not recruiting | Sponsor: EuBiologics Co.,Ltd | Recruiting ➔ Active, not recruiting | Trial primary completion date: Mar 2025 ➔ Jul 2025

Enrollment closed • Trial primary completion date • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years (clinicaltrials.gov) - P1 | N=100 | Recruiting | Sponsor: EuBiologics Co.,Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections